Urology Doctors in Newark, NJ Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Kunj Jain, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 185 S Orange Ave, Newark, NJ 07103 Phone: 732-445-4636

Mark Louis Jordan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 90 Bergen St, Doc 2300, Newark, NJ 07103 Phone: 973-972-2888    Fax: 973-972-2892

Dr. Evan Kovac, MD CM FRCSC Urology Medicare: Accepting Medicare Assignments Practice Location: 140 Bergen St Rm G-1680, Newark, NJ 07103 Phone: 973-972-4418

Dr. Gina Cambareri, MD Urology - Pediatric Urology Medicare: Medicare Enrolled Practice Location: 201 Lyons Ave, L5, Newark, NJ 07112 Phone: 973-926-7280

David S Ali, Urology Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Newark, NJ 07103 Phone: 973-972-5682

News Archive

Researchers develop new microscope system that can image living tissue in real time

A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes, report researchers at the University of Illinois.

U-M's minimally invasive revascularization procedure can treat peripheral arterial disease

Henry Gibbs, 58, is a ballroom dance instructor, but he was forced to hang up his dancing shoes when a circulation condition, common among older adults, caused severe leg pain and cramping.

Medical education is a process of socialisation - into the population that the future doctors will serve

Allowing medical students to interact with patients earlier in their medical course would better prepare them for their future role as a doctor, suggest researchers in this week's BMJ.

Harbor BioSciences to receive patent for Apoptone in treatment of prostate cancer, breast cancer and benign prostatic hypertrophy

Harbor BioSciences, Inc. today announced that the company has received a notice of allowance from the United States Patent Office of patent claims covering the use of its lead product candidate Apoptone®. The patent claims cover the use of Apoptone to treat prostate cancer, breast cancer and benign prostatic hypertrophy. Apoptone (HE3235) is a novel synthetic steroid analog of a dihydrotestosterone metabolite and has been found to stimulate cell death (apoptosis) in animal models of prostate and breast cancers.

Read more Medical News

› Verified 9 days ago